A phase 1 study of oral ridaforolimus in pediatric patients with advanced solid tumors

por Pearson, Andrew D.J., Federico, Sara M., Aerts, Isabelle, Hargrave, Darren R., DuBois, Steven G., Iannone, Robert, Geschwindt, Ryan D., Wang, Ruixue, Haluska, Frank G., Trippett, Tanya M., Geoerger, Birgit
Publicado 2016

Factors associated with recurrence and survival length following relapse in patients with neuroblastoma

por Basta, Nermine O, Halliday, Gail C, Makin, Guy, Birch, Jillian, Feltbower, Richard, Bown, Nick, Elliott, Martin, Moreno, Lucas, Barone, Giuseppe, Pearson, Andrew DJ, James, Peter W, Tweddle, Deborah A, McNally, Richard JQ
Publicado 2016

Individualized (131)I-mIBG therapy in the management of refractory and relapsed neuroblastoma

por George, Sally L., Falzone, Nadia, Chittenden, Sarah, Kirk, Stephanie J., Lancaster, Donna, Vaidya, Sucheta J., Mandeville, Henry, Saran, Frank, Pearson, Andrew D.J., Du, Yong, Meller, Simon T., Denis-Bacelar, Ana M., Flux, Glenn D.
Publicado 2016

Selective FLT3 inhibition of FLT3-ITD(+) acute myeloid leukaemia resulting in secondary D835Y mutation: a model for emerging clinical resistance patterns

por Moore, Andrew S., Faisal, Amir, de Castro, David Gonzalez, Bavetsias, Vassilios, Sun, Chongbo, Atrash, Butrus, Valenti, Melanie, de Haven Brandon, Alexis, Avery, Sian, Mair, Debbie, Mirabella, Fabio, Swansbury, John, Pearson, Andrew D.J., Workman, Paul, Blagg, Julian, Raynaud, Florence I., Eccles, Suzanne A., Linardopoulos, Spiros
Publicado 2012

Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1)

por Ladenstein, Ruth, Pötschger, Ulrike, Valteau-Couanet, Dominique, Luksch, Roberto, Castel, Victoria, Ash, Shifra, Laureys, Geneviève, Brock, Penelope, Michon, Jean Marie, Owens, Cormac, Trahair, Toby, Chi Fung Chan, Godfrey, Ruud, Ellen, Schroeder, Henrik, Beck-Popovic, Maja, Schreier, Guenter, Loibner, Hans, Ambros, Peter, Holmes, Keith, Castellani, Maria Rita, Gaze, Mark N., Garaventa, Alberto, Pearson, Andrew D.J., Lode, Holger N.
Publicado 2020

Combination Early-Phase Trials of Anticancer Agents in Children and Adolescents

por Moreno, Lucas, DuBois, Steven G., Glade Bender, Julia, Mauguen, Audrey, Bird, Nick, Buenger, Vickie, Casanova, Michela, Doz, François, Fox, Elizabeth, Gore, Lia, Hawkins, Douglas S., Izraeli, Shai, Jones, David T.W., Kearns, Pamela R., Molenaar, Jan J., Nysom, Karsten, Pfister, Stefan, Reaman, Gregory, Smith, Malcolm, Weigel, Brenda, Vassal, Gilles, Zwaan, Christian Michel, Paoletti, Xavier, Iasonos, Alexia, Pearson, Andrew D.J.
Publicado 2023

Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents()

por Pearson, Andrew. D.J., Zwaan, C.Michel, Kolb, E.Anders, Karres, Dominik, Guillot, Julie, Kim, Su Young, Marshall, Lynley, Tasian, Sarah K., Smith, Malcolm, Cooper, Todd, Adamson, Peter C., Barry, Elly, Benettaib, Bouchra, Binlich, Florence, Borgman, Anne, Brivio, Erica, Capdeville, Renaud, Delgado, David, Faller, Douglas V., Fogelstrand, Linda, Fraenkel, Paula Goodman, Hasle, Henrik, Heenen, Delphine, Kaspers, Gertjan, Kieran, Mark, Klusmann, Jan-Henning, Lesa, Giovanni, Ligas, Franca, Mappa, Silvia, Mohamed, Hesham, Moore, Andrew, Morris, Joan, Nottage, Kerri, Reinhardt, Dirk, Scobie, Nicole, Simko, Stephen, Winkler, Thomas, Norga, Koen, Reaman, Gregory, Vassal, Gilles
Publicado 2020